Magenta Therapeutics' Series B Round

Magenta Therapeutics raised a round of funding on May 02, 2017.

Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases.Magenta Therapeu…

Articles about Magenta Therapeutics' Series B Round: